In kidney transplant recipients, cancer is one of the leading causes of death with a
functioning graft beyond the first year of kidney transplantation, and malignancies account …

Context Cryoablation (CA) is a minimally invasive modality with low complication rates, but
its use in urology is relatively recent. Objective To summarize available evidence for CA for …

Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …

Life expectancies for solid organ recipients as well as graft survival rates for these patients
have improved over the years because of advanced immunosuppressive therapies; …

Objective. To analyze the diagnosis and treatment of patients with concomitant malignant
tumors after organ transplantation by compiling data from organ transplantation patients …

Background Cancer risk is increased by 2-to 4-fold in kidney transplant recipients (KTRs)
compared with the general population. Little attention, however, has been given to KTRs …

BACKGROUND Polyomavirus-associated nephropathy is a leading cause of kidney allograft
failure. Therapeutic options are limited and prompt reduction of the net state of …

Objectives To evaluate survival and outcomes after percutaneous radiofrequency ablation
(RFA) of malignant renal tumours in high-risk patients with long-term follow-up. Methods …

Thermal ablation of small renal masses is increasingly accepted as an alternative to partial
nephrectomy, particularly in patients with multiple comorbidities. Many professional societies …

Kidney transplant recipients are at increased risk for malignancy, with about 5% incidence of
cancer in native end-stage kidneys. Carcinoma in the renal allograft is far less common …